See all awarded grants for 2017.
Asthma is a chronic inflammatory disease of the lungs. This glossary explains asthma terms, such as bronchodilator, anti-inflammatory medicine, inhaler, corticosteroid and spirometry.
Noise anxiety is a common phobia among dogs. Treatment should always be targeted as a dog's behavior may be caused by a variety of reasons.
Prostate cancer is the most widespread form of cancer that affects men, and approximately 5,000 men are diagnosed with prostate cancer every year. This form of cancer usually develops slowly and does not necessarily produce any symptoms. Forms of treatment are surgery or radiation therapy.
Wearing-off is a term that refers to a fluctuation in the symptoms of a person suffering from Parkinson’s disease. The patient’s symptoms fluctuate depending on the effects of the medication and the symptoms of the disease.
Orion develops new pharmaceuticals in three therapy areas. Orion’s pharmaceutical R&D focuses on the central nervous system, cancer and critical care, and inhalable Easyhaler® pulmonary drugs. Orion also develops veterinary and generic drugs.
The Orion R&D aims to be the best in the world. Reijo Salonen, Senior Vice President of R&D, tells why and how.
What does it take to develop a new medicine? To start with, you need a dedicated team of top scientists and other professionals. The journey might take up to fifteen years. Take a look!
Here we provide for download scientific publications released at congresses in which Orion is participating or in other contexts.
The 2017 Annual General Meeting of Orion was held on Wednesday, 22 March 2017 in Messukeskus Helsinki, Exhibition and Convention Centre.
Read Orion's Financial Statements for 2016 in the archive of Orion's Annual Reports and Financial Statements.
The latest Corporate Governance Statement of Orion Corporation is available at the archive of Corporate Governance Statements.
One key area of Orion's business is Critical Care. Our portfolio includes Simdax® for acute heart failure and Precedex® and Dexdor® for sedation. Read more about Orion's proprietary products and other human pharmaceuticals.
|4/26/2017||Orion Group Interim Report January-March 2017|
|4/19/2017||398,245 Orion Corporation A shares converted into B shares|
|4/12/2017||Publishing of Orion Corporation's Interim Report for January-March 2017 on 26 April 2017|
|4/6/2017||Amendment to Sections 5 and 9(1) of the Articles of Association of Orion Corporation entered in the Trade Register|
Orion is the largest employer in the Finnish pharmaceutical industry. It is considered to be a good and reliable employer, which is also indicated by its lower-than-average employee turnover.
How do I apply for a job at Orion? Can I attach my CV to the application form? How can I make sure my job application stands out from the rest? These following tips will help you complete your job application.
Are you a physician, vet, pharmacist or another healthcare professional? 'Health Professionals' site offers an easy access to our websites for professionals.